Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are secreted by enteroendocrine cells and augment insulin secretion in response to food ingestion in a glucose-dependent manner
Dual-WAC allows the manufacturer to be competitive in both formulary environments simultaneously
Jennifer Peleshok, Anita Y
The only indication that there may be risks associated with taking the companies products came in the last line of a long written disclaimer at the end of the ad: See website for details and important safety information. (A similar disclaimer appears at the end of the Hims ad focusing on its ED medication.) Since the controversy over the Super Bowl ad, Hims and Hers have included a disclaimer in some of their ads regarding how their compounded weight-loss products have not been approved by the FDA and require an online consultation with a licensed provided who will determine if a prescription is appropriate. But the disclaimer doesnt appear everywhere and it still refers consumers to a company website for important safety information. As for the other telehealth companies mentioned earlier, Willow does not disclose any side effects associated with its compounded GLP-1 products in the social media post shown above and requires that consumers scroll more than halfway down product pages to learn about potential health risks
Average weight loss after 12 weeks: Up to 6% By the 12-week mark, you could lose up to 6% of your body weight [1]
US$ 27.15
US$ 23.45
US$ 27.03
US$ 28.96
US$ 23.20
US$ 20.62
US$ 23.97
